market Inner Banner
  • BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ticker-arrow
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
Lupin Q4 PAT jumps 87.72%; EBITDA margin expands 1,070 bps
(12:42, 08 May 2026)
Consolidated profit after tax stood at Rs 1,468.70 crore in Q4 FY26, up 87.72% from Rs 782.40 crore in Q4 FY25 and higher by 24.42% from Rs 1,180.50 crore in Q3 FY26.

Net sales rose 32.9% to Rs 7391.91 crore in Q4 FY26 from Rs 5562.2 crore in Q4 FY25. It increased 4.1% sequentially from Rs 7100.5 crore in Q3 FY26.

Gross profit excluding other operating income stood at Rs 5,540.30 crore in Q4 FY26, up 42.90% from Rs 3,876 crore in the year-ago quarter. Gross margin expanded to 75% from 69.7% in Q4 FY25 and 73.5% in Q3 FY26.

Profit before tax stood at Rs 1,928 crore in Q4 FY26, up 115.22% from Rs 895.80 crore in Q4 FY25 and higher by 26.68% from Rs 1,522 crore in Q3 FY26.

EBITDA stood at Rs 2,626.30 crore in Q4 FY26, up 90.57% from Rs 1,378.10 crore in Q4 FY25 and higher by 10.51% from Rs 2,376.60 crore in Q3 FY26. EBITDA margin expanded 1,070 bps YoY to 35.5% from 24.8% and improved 200 bps sequentially from 33.5% in Q3 FY26.

Geographically, the U.S. market remained the largest contributor to sales during Q4 FY26, with revenue rising 56.90% YoY to Rs 3,398.70 crore. India sales increased 11.51% to Rs 1,908.20 crore, while emerging markets revenue climbed 49.21% to Rs 990.60 crore. Revenue from other developed markets rose 7.15% to Rs 845.30 crore.

Total formulations sales grew 34% YoY to Rs 7,142.80 crore, while API revenue increased 7.60% to Rs 249.10 crore. Total product sales rose 32.90% to Rs 7,391.90 crore in Q4 FY26.

Material cost increased 9.81% YoY to Rs 1,851.60 crore, while employee cost rose 24.11% to Rs 1,242.70 crore. Manufacturing and other expenses climbed 30.91% to Rs 2,209.30 crore. Finance cost rose 34.90% YoY to Rs 120.20 crore, while depreciation, amortization and impairment expense increased 13.63% to Rs 446.80 crore.

Other income surged 146.84% YoY to Rs 140.70 crore during the quarter. Forex gain stood at Rs 314.50 crore against a forex gain of Rs 29.10 crore in Q4 FY25.

Exceptional items for Q4 FY26 stood at Rs 131.30 crore compared with nil in the corresponding quarter last year.

Investment in research and development for the quarter stood at Rs 589.80 crore, equivalent to 8.0% of sales.

Operating working capital stood at Rs 7,132.40 crore as of quarter-end, while operating days stood at 87 days.

Capital expenditure for Q4 FY26 stood at Rs 305.20 crore. For the full year, capex stood at Rs 1,061.80 crore.

The company reported net debt of negative Rs 4,635.80 crore as of 31 March 2026. Net debt-to-equity ratio stood at negative 0.21, indicating a net cash position.

For the full year ended 31 March 2026, net sales increased 23.9% to Rs 27487.50 crore from Rs 22192.10 crore in FY25. Profit before tax rose 71.17% to Rs 6,872.60 crore from Rs 4,015 crore in FY25, while profit after tax increased 61.98% to Rs 5,355.50 crore from Rs 3,306.30 crore.

Full-year EBITDA jumped 68.64% to Rs 9,240.50 crore from Rs 5,479.20 crore. EBITDA margin expanded 890 bps to 33.6% from 24.7%.

Net cash from operating activities surged to Rs 7,334.50 crore in FY26 from Rs 2,999.94 crore in FY25.

Managing director Nilesh Gupta said the company's Q4 and FY26 performance reflected strong sales growth and margin expansion in the U.S. and India markets, supported by investments in technology, execution and operational efficiencies.

Lupin is a global pharmaceutical company focused on branded and generic formulations, complex generics, biotechnology products and active pharmaceutical ingredients across multiple therapeutic segments.

Shares of Lupin fell 3.51% to Rs 2373.50 on the BSE.

Powered by Capital Market - Live News

.
Stock Broker Name Registration Number Registered Address Branch Address Contact Number Email id
DB (International) Stock Brokers Limited INZ000179035 (BROKING)

IN-DP-CDSL-266-2004 (DEPOSITORY)
Unit No. 210/211/211A at 2nd floor, Dalal Street Commercial Cooperative Society Ltd, Block No.53, Zone 5, Gift City, Gandhinagar, Gujarat-382355
51, Mini Market T/F Mandir Wali Gali, Yusaf Sarai, New Delhi 110016 011-35936102 greenpark@dbonline.in
C-12, DB Plaza, RDC Raj Nagar, Ghaziabad 201002 0120-4150393 ghaziabad@dbonline.in
Plot No 4, Wasme House, Film City Sector 16A, Noida – 201301 0120-4823200 compliance@dbonline.in
Out Side Jassusar Gate, Bikaner, Rajasthan – 334001 9001643408 bikaner@dbonline.in
Office No 101, City Center, Opp. High Court, M G Road, Indore 452001 9424083019 brajeshsadani@dbonline.in
203, Marshal House 25, Strand Road, Kolkata 700001 033-40055270 b032@dbonline.in
Shop No.-7, 2nd Floor, Amar Complex, Opp. Hanumaan Mandir, The Mall, Solan- 173212 6230604596 parwanoo@dbonline.in
Daga Commodities Private Limited INZ000028833 114, New Delhi House, 27 Barakhamba Road, Delhi 110001- 0120-4823200 compliance@dbonline.in
Daga Business (International) Stock Brokers (IFSC) Private Limited INZ000202436 Unit No. 228, Signature Building, Second Floor, Block 13B, Zone-1, Gift SEZ, Gandhinagar, Gujarat 382355 - 0120-4823200 compliance@dbonline.in

Disclosure regarding proprietary trading:

As required under Circular No. SEBI/MRD/SE/Cir-42/2003 dated 19.11.2003 issued by the Securities and Exchange Board of India; We hereby disclose that in addition to client based business, We are also doing proprietary trading.

Investor Grievances Email ID: investorgrievance@dbonline.in


Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries | Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. | Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors"